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Abstract:  Cadmium (Cd) is frequently used in various industrial applications and is a ubiquitous environmental 
toxicant, also present in tobacco smoke. An important route of exposure is the circulatory system whereas blood 
vessels are considered to be main stream organs of Cd toxicity. Our previous results indicate that cadmium chloride 
(CdCl2) affects mean arterial blood pressure in hypertensive rats. We hypothesized that Cd alters the intracellular 
calcium transient mechanism, by cadmium-induced stimulation of MAPKs (ERK 1 & 2) which is mediated partially 
through calcium-dependent PKC mechanism. To investigate this hypothesis, we exposed primary cultures of vascular 
smooth muscle cells (VSMCs) from wistar kyoto (WKY) and spontaneously hypertensive rats (SHR) to increased 
concentrations of CdCl2 on cell viability, expression of mitogen-activated protein kinases (MAPKs/ERK 1 & 2), and 
protein kinase C (PKC) which are activated by Cd in several cell types. The results from these studies indicate that 
CdCl2 decreased cell viability of both SHR and WKY VSMCs in a concentration dependent-manner. Viability of both 
cell types decreased 33±5.3 (SHR) and 39±2.3% (WKY) when exposed to 1 µM CdCl2, whereas, 8 and 16 µM 
reduced viability by 66±3.1 and 62±4.5% in SHR cells. CdCl2 increased ERK 1 & 2 in a biphasic manner with 
maximum increase occurring when cells are exposed to 1 and 4 µM in SHR VSMCs, whereas,  a reduction in ERK 1 
and 2 is observed when WKY cells are treated with 2 µM. The results also indicate that CdCl2 increased PKC a/ß in 
both SHR and WKY VSMCs with a greater increase in expression in SHR VSMCs.  In addition, the [Ca2+]i chelator, 
BAPTA, suppressed the CdCl2 effect, whereas, the PKC inhibitor, GF109203X, reduced the CdCl2 induced-effect on 
PKC expression. The present studies support the hypothesis that Cd can be a risk factor of hypertension through 
dysfunction of vascular smooth muscle cells under certain conditions.  
Keywords:  Protein kinase C; mitogen-activated protein kinase; ERK 1; ERK 2; vascular smooth muscle cells.   
Introduction  
Cd is frequently used in various industrial activities 
and is a ubiquitous environmental toxicant, also present 
in tobacco smoke. An important route of exposure is the 
circulatory system whereas blood vessels are considered 
to be main stream organs of Cd toxicity. Cd exposure via 
the respiratory system has been studied [1] and it has 
been reported that Cd causes apoptosis in various cell 
types in vitro [2]. We have shown that CdCl2 increases 
blood pressure in both SHR and WKY rats and chronic 
exposure of VSMCs of rats with CdCl2 leads to apoptosis 
(unpublished results). However, the mechanism involved 
in the elevation of blood pressure and the apoptotic effects 
of CdCl2 has not been determined.  
The evidence indicates that the mitogen-activated 
protein kinase (MAPK) cascade is involved in the 
regulation of cell growth, differentiation, and various 
cellular stress responses which is mediated through 
intracellular signal transduction in response to a variety of 
stimuli [3, 4]. More recently, MAPK has been studied in 
response to other stresses [5-7] to gain an understanding of 
the MAPK signaling mechanisms, specifically, in 
cardiovascular disorders [8, 9].  
Also, the cellular mechanisms involved in triggering 
and development of atherosclerosis induced by Cd may 
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include MAPKs and other signal transduction systems, 
such as protein kinase C (PKC). Since the discovery that 
PKC is the high affinity intracellular receptor of phorbol 
esters, it is widely accepted that PKC plays a role in the 
regulation of proliferation and differentiation [10, 11]. 
As these processes involve nuclear regulatory control, it 
is thought that PKC must be involved in mediating 
nuclear responses to both mitogenic and differentiation 
factors [12, 13]. In fact, substantial evidence indicates a 
direct role for PKC in linking cell membrane receptor 
binding events to responses at the genome level. 
It is our hypothesis that CdCl2 alters the calcium 
transient mechanism through cadmium-induced 
stimulation of MAPK (ERK 1 & 2) which is mediated 
partially through calcium-dependent PKC mechanism. In 
this study we are providing evidence to support this 
hypothesis by reporting the results of specific MAPKs 
and PKC-a/ß activation following stimulation with 
CdCl2 in VSMCs from a hypertensive phenotype. The 
results indicate that ERK 1 and 2 along with PKC-a/ß 
are reduced or inhibited within 5 min of stimulation in 
SHR cells which may be the results of Cd competing 
with intercellular calcium ([Ca2+]i) in activation of the 
pathways for these intermediates.   
Materials and Methods  
Materials  
Dulbecco’s Modified Eagle’s medium was obtained 
from Cambrex BioScience (Walkersville, MD), fetal 
bovine serum, and penicillin/streptomycin, both 
purchased from Biowhittaker (Walkersville, MD). For 
experimental procedures, CdCl2 was obtained from 
Sigma Chemical Company (St. Louis, MO) along with 
the calcium chelator, BAPTA-AM. The PKC inhibitor, 
GF109203X, was purchased from Tocris (Ballwin, MO). 
SDS-Polyacrlymide gels (precast) were ordered from 
BioRad Laboratories (Hercules, CA) and nitrocellulose 
membrane from Amersham Biosciences (Piscataway, 
NJ). Primary antibodies for MAPK and Protein Kinase 
C-a/ß were ordered from Cell Signaling (Beverly, MA) 
and used for western blotting analysis. To detect and 
image the primary MAPK and PKC primary antibodies, 
Anti-rabbit IgG secondary antibodies (horseradish 
peroxidase linked) was obtained from Amersham 
Bioscience (Piscataway, NJ) and chemiluminescent 
(ECL) detection system was obtained from Pierce 
Biotechnology (Rockford, IL).  
Cell Culture and Treatment  
Vascular smooth muscle cells were obtained from 
Dr. Evangeline Motley (Meharry Medical College) and 
cultured in DMEM containing 10% fetal calf serum, 
penicillin, and streptomycin. Sub-cultured VSMCs from 
passages 3-12, used in the experiments, were seeded into 
conventional plastic tissue culture plates (Falcon) and 
cultured in DMEM containing 10% fetal calf serum in a 
humidified atmosphere of 5% CO2 and O2. CdCl2 was 
prepared in DMEM at 50 mM just before application. After 
cells were confluent, cells were incubated for the desired 
time periods with desired concentrations of CdCl2.  
Western Blot Analysis of MAPK and PKC Expression  
Cells grown in 6 well plates were stimulated in the 
presence or absence of the desired concentrations of CdCl2 
at 37ºC for specified durations. The reactions were 
terminated by the replacement of medium with 100 µl of 
SDS-polyacrylamide gel electrophoresis buffer, pH 6.8, 
containing 62.5 mM Tris-HCl, 2% SDS, 10% glycerol, 50 
mM dithiothreitol, and 0.1% bromophenol blue. Samples 
were sonicated briefly, followed by a one minute flash 
spin. Samples were then boiled for three min and 
centrifuged at 10,000 RPM for 5 min and supernatant (20 
µg) was subjected to  a 10% SDS-polyacrylamide gel. 
Proteins in the gel were transferred to a nitrocellulose 
membrane using the semi-dry transfer method. The 
membrane was then blocked for non-specific binding for 
one hr with 5% non-fat dry milk. Primary antibodies 
specific for ERK 1 & 2 and PKC-a/ß were gently rocked at 
4ºC over the membrane overnight and washed before the 
membrane was submerged in the secondary antibody for 
one hr. After washing, the membrane was incubated with 
secondary anti-rabbit antibodies and immunoreactive 
proteins were detected by the ECL.  
Cell Viability  
VSMCs viability was assessed by using trypan blue 
exclusion. Briefly, the cells were plated in wells of 6 –well 
cluster plate and grown to confluence for 48 hr. After 
treatment with CdCl2, the cells were harvested by trypsin 
digestion, centrifuged at 1200 x g for 10 min at 4ºC, and 
examined by adding an equivalent volume of a 0.4% 
trypan blue solution to an aliquot of the re-suspended cells. 
The re-suspended cells were incubated for 5 min and the 
stained and unstained cells were counted by means of a 
hemocytometer.  
Statistics  
Each experiment was repeated at least 3 times. The 
effects of cadmium or antagonists on MAPK and PKC 
expression were plotted using a statistic program, prism 
(GraphPad Software, San Diego, CA). We performed 
densitometric analysis of images from Western blotting 
with a molecular imaging system (BioRad). The results are 
the mean±SEM and compared by ANOVA of Student-t test 
where appropriate. A value of p<0.05 was considered 
significant.  
Results  
The effects of CdCl2 on VSMCs viability are shown in 
figure 1. CdCl2 (1-16 µM) exposure of SHR and WKY 
VSMCs for 24 hr resulted in a statistically significant 
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concentration-related decrease in cell viability for both 
cell types. VSMCs viability for both cell types decreased 
33 and 39%, respectively, when cells were treated with 1 
µM of CdCl2. A significant decrease in cell viability was 
observed between the two cell types of 6%.  Maximum 
decreases in cell viability observed after cells were 
treated with concentrations of CdCl2 (8 and 16 µM) were 
66±3.1 and 62±4.5% for SHR cells. This decrease in cell 
viability was observed to be significantly higher in WKY 
cell types, 63±1.5 and 75±5.0%, respectively.  
 
A: CdCl2 effect on cell viability of SHR VSMCs   
B: CdCl2 effect on cell viability of WKY VSMCs   
Figure 1: Effect of CdCl2 on Cell viability of SHR and 
WKY vascular smooth muscle cells. Cell viability was 
assessed following incubation of cells with CdCl2 for 24 
hr using the trypan blue exclusion method. The mean 
levels of cell viability for treating cells with 1-16 µM of 
CdCl2 on SHR VSMCs (A) were 66.6±10.5, 44.0±12.8, 
33.7±2.6, and 37.5±6.8% and WKY VSMCs (B) were 
61±13.5, 45.5±5.9, 36.3±2.7, and 25.3±9.5%, 
respectively. The data are the mean± SEM of 3 different 
experiments. *Significantly different from time-matched 
control, p<0.05. 
A: CdCl2 effect on MAPK expression of SHR VSMCs   
B: CdCl2 effect on MAPK expression of WKY VSMCs  
Figure 2:   A concentration dependent effect of CdCl2 on 
expression of ERK 1 & 2 in VSMCs of (A) SHR and (B) 
WKY rats.  VSMCs were stimulated with 1-16 µM of 
CdCl2. Cell were harvested in lysis buffer as described in 
Material and Methods, and equal protein concentrations (20 
µg) were analyzed on a 10% polyacrylamide gel and 
transferred to a nitrocellulose membrane. ERK 1 & 2 were 
determined by measuring specific phosphorylated ERK 1 & 
2 (pp44 ERK-1 and pp42 ERK-2) by western blot. 
Densitometric analysis of western blots was done to quantify 
the magnitude of change in phosphorylation of MAPKs 
induced by CdCl2. Bar graph represents intensities of ERK 1 
& 2 bands. The data are the mean± SEM of 3 to 4 different 
experiments. *p<0.05 compared to time-matched control. 
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We also investigated the effect of CdCl2 on 
expression of ERK 1 and 2. The results indicated that 
CdCl2 activated ERK 1 and 2 in a biphasic manner in 
VSMCs of SHR. Maximum activation of ERK 1 and 2 
was observed with 1 and 4 µM of CdCl2 with 8 µM 
having similar effects on MAPK expression as that was 
observed with 4 µM.
 
Expression of ERK 1 and 2 
increased 80±3.6 and 85±4.2%, respectively, of control 
and was suppressed with 2 and 16 µM of CdCl2 shown in 
figure 2A. Treating WKY VSMCs with similar 
concentrations of CdCl2, expression of ERK 1 and 2 was 
initially reduced with 2 µM, whereas, 4 µM increased 
expression by 77±5.1% of control shown in figure 2B. It 
was also observed that 16 µM reduced expression of 
ERK 1 and 2 in a similar manner as that  observed when 
VSMCs of SHR were treated with similar concentrations 
of CdCl2. 
The time of activation of ERK 1 and 2 in VSMCs 
with 4 µM CdCl2 is shown in figure 3A and 3B. The 
expression of ERK 1 and 2 was suppressed for the first 2 
min in SHR VSMCs. Five (5) min of exposure seem to 
reduce expression which was followed by a time-
dependent increase in expression at 15 min in SHR 
VSMCs shown in figure 3A. This increase remained 
present up to 60 min of exposure, whereas, the 
expression of ERK 1 and 2 increased dramatically within 
5 min after exposing WKY VSMCs to CdCl2.  Maximum 
expression of ERK 1 and 2 in WKY cells was observed 
within 5 min of exposure followed by a reduction in 
ERK 2 for 10-60 min shown in figure 3B.   
A: Time Course on the effect of CdCl2 on ERK 1 & 2 
Expression in SHR  
B: Time Course on the effect of CdCl2 on ERK 1 & 2 
Expression in WKY  
Figure 3:   A time course effect of CdCl2 on expression 
of ERK 1 & 2 in VSMCs of (A) SHR and (B) WKY rats.  
VSMCs were stimulated with 4 µM of CdCl2 for the 
specified time 1-60 min. Cell were harvested in lysis 
buffer as described in Material and Methods, and equal 
protein concentrations (20 µg) for each sample were 
analyzed on a 10% polyacrylamide gel and transferred to 
a nitrocellulose membrane. ERK 1 & 2 were determined 
by measuring specific phosphorylated ERK 1 & 2 (pp44 
ERK-1 and pp42 ERK-2) by western blot.  
Next, we examined the effect of CdCl2 on PKC 
expression in both SHR and WKY VSMCs shown in figure 
4A and 4B. CdCl2 increased PKC–a/ß expression in a 
concentration and time dependent manner with maximum 
expression observed within 15 min of exposing SHR cells 
to 4 µM, whereas, maximum expression of PKC- a/ß was 
obtained in WKY cells when cells were exposed 30 min or 
longer. We also investigated whether the [Ca2+]i and PKC 
pathway are link to the CdCl2 effect observed in SHR cells. 
GF109203X, the PKC inhibitor, reduced the CdCl2 
induced-effect by 32±2.5% whereas BAPTA suppressed 
the CdCl2 effect which is shown in figure 5.  
A: Time Course on the effect of CdCl2 on PKC Expression 
in SHR  
B: Time Course on the effect of CdCl2 on PKC Expression 
in WKY  
Figure 4: A time-dependent effect of CdCl2 on expression of 
PKC in VSMCs of SHR (A) and WKY (B). Cells were 
stimulated with 4 µM of CdCl2 for 1-60 min. Cells were 
harvested in lysis buffer as described in Material and Methods, 
and equal protein concentrations (20 µg) were analyzed on a 
10% polyacrylamide gel and transferred to a nitrocellulose 
membrane. PKC-a/ß expression was determined by measuring 
specific phosphorylated PKC-a/ß by western blot.
The antagonistic effects of various antagonists on CdCl2 
induced PKC Expression   
Figure 5: The antagonistic actions of GF109203X (GF) and 
BAPTA on CdCl2 induced stimulation of PKC-a/ßII 
expression in SHR VSMCs. Cells were stimulated with 4 µM 
of CdCl2 for 5 min following treatment for 1 hr with each 
antagonist. PKC-a/ß expression was determined by measuring 
specific phosphorylated PKC-a/ß by western blot. 
Densitometric analysis of western blots was done to quantify 
the magnitude of change in phosphorylation of MAPKs 
induced by CdCl2. Bar graph represents intensities of MAPK 
bands. The data are the mean± SEM of 3 to 4 different 
experiments. *p<0.05 compared to time-matched control. 
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Discussion  
It has also been shown that Cd exposure rapidly 
increases inositol 1, 4, 5,-triphophate and then triggers 
Ca2+ mobilization in various cell types [14, 15].  Also, it 
has been shown that pre-treatment with an intracellular 
Ca2+ chelator, BAPTA/AM, suppresses CdCl2 induced 
MAPKs in renal epithelial and CCRF-CEM cells [16]. In 
the present study, we examined the effect of CdCl2 on 
MAPK and PKC expression in VSMCs of SHR. The 
results indicate that CdCl2 decreased cell viability of 
both SHR and WKY cells in a concentration dependent 
manner. Furthermore, it appears that CdCl2 activates 
ERK 1 & 2 in a biphasic manner in SHR VSMCs and 
that PKC a/ß expression is more sensitive to CdCl2 
effects than what was observed in WKY VSMCs.  Also, 
CdCl2 induced effect is suppressed with the intracellular 
Ca2+ chelator, BAPTA and is reduced significantly with 
the PKC inhibitor, GF109203X which may indicate that 
the mediated effect of Cd is link to the mobilization of 
calcium through the MAPK and PKC pathways which  
share a role in the proprogating of the signal generated 
by Cd. 
It is also known that MAPKs mediate intracellular 
signal transduction in response to a variety of stimuli 
[3,4]. The MAPK family members are themselves 
activated by reverse dual phosphorylation on the Thr and 
Tyr residues in the catalytic domain. Three major 
MAPKs have been identified, the extra cellular signal-
regulated kinases (ERK1 and 2), the stress-activated 
protein kinases c-Jun NH2-terminal kinases (JNK) and 
p38 mitogen activated protein kinases. It seems that Cd 
exposure rapidly increases inositol 1, 4, 5,-triphosphate 
and then triggers Ca2+ mobilization in various cell types 
[14, 15] and that pre-treatment with an intracellular Ca2+ 
chelator, BAPTA, suppresses CdCl2-induced JNK.  The 
results from these studies showed that intracellular Ca2+ 
plays a role in CdCl2-induced activation of ERK, JNK, 
and 38 MAPK in CCRF-CEM cells [17].  
We previously observed that in hypertensive rat, Cd 
increased blood pressure and heart rate. Also Cd 
exposure has been implicated in Hypertension and 
atherosclerotic lesion [18, 19]. The frequencies of ten 
diseases in a Cd-contaminated region in the Netherlands 
[20] were investigated and it was found that a 
significantly higher frequency for atherosclerosis 
occurred which indicated a relationship between Cd 
exposure and cardiovascular disease epidemiologically 
[21] and in Cd exposed pigeons, not only hypertension 
but also atherosclerotic lesion was observed [18].  
In conclusion, it was found that Cd can decrease cell 
viability and can activate MAPKs and PKC expression in 
SHR VSMCs. An intracellular calcium-dependent 
pathway is suggested to be involved in the Cd mediated 
effect which may lead to its contribution to hypertension 
through the dysfunction of VSMCs.  
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